Mirit Horenshtein Hadar
Chief Financial Officer (formerly EVP Finance of Silexion Israel)
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Silexion Therapeutics Corp (SLXN) | Chief Financial Officer (formerly EVP Finance of Silexion Israel) | $233,532 | $770,090 |
| 2023 | Silexion Therapeutics Corp (SLXN) | Chief Financial Officer (formerly EVP Finance of Silexion Israel) | $26,238 | $26,238 |
Earnings-call appearances
No earnings-call appearances recorded yet.